Lifestance Health Group Inc
NASDAQ:LFST
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
thyssenkrupp nucera AG & Co KgaA
XETRA:NCH2
|
DE |
|
I
|
Infineon Technologies AG
OTC:IFNNY
|
DE |
|
Yara International ASA
OTC:YARIY
|
NO |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its Industry Average (19.2), the stock would be worth $1.19 (83% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 112 | $6.92 |
0%
|
| Industry Average | 19.2 | $1.19 |
-83%
|
| Country Average | 19.6 | $1.21 |
-82%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
$2.5B
|
/ |
Jan 2026
$24.1m
|
= |
|
|
$2.5B
|
/ |
Dec 2026
$64.7m
|
= |
|
|
$2.5B
|
/ |
Dec 2027
$115.7m
|
= |
|
|
$2.5B
|
/ |
Dec 2028
$183.9m
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Lifestance Health Group Inc
NASDAQ:LFST
|
2.7B USD | 112 | 278.1 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
97.3B USD | 14 | 55 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69B EUR | 9.9 | 13.3 | |
| US |
|
Cigna Corp
NYSE:CI
|
73.7B USD | 0 | 12.4 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.7B EUR | 14.5 | 19.5 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 16.8 | 23.6 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.1B USD | 17.5 | 25.2 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.6B USD | 16 | 21.9 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11B EUR | 10 | 11.3 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.9B USD | -28.4 | -28.6 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.2B USD | 9.7 | 13.7 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.6 |
| Median | 19.6 |
| 70th Percentile | 27.8 |
| Max | 1 826 183.2 |
Other Multiples
Lifestance Health Group Inc
Glance View
LifeStance Health Group Inc., emerging as a prominent player in the rapidly evolving behavioral health sector, operates with a mission to positively impact the lives of individuals facing mental health challenges across the United States. Founded in 2017, the company recognized the increasing demand for accessible, high-quality mental health services amidst a backdrop of rising awareness and destigmatization of mental health issues. LifeStance Health offers a comprehensive range of services, including therapy, psychiatric evaluations, and medication management. It facilitates these services both online through telehealth platforms and in-person at a multitude of clinics, effectively bridging the gap between patients and care providers. The adaptability of their hybrid model not only expands their reach but also caters to varying patient needs, particularly crucial in a post-pandemic world where digital solutions have become indispensable. LifeStance Health generates revenue through a fee-for-service business model, deriving income primarily from patient billing and insurance reimbursements. The company's network comprises a diverse array of licensed therapists, psychiatrists, and psychologists who deliver personalized care, thus operating both as salaried employees and through revenue-sharing arrangements at their numerous practice locations. By scaling a vast provider network, LifeStance maintains significant leverage with insurance companies, negotiating favorable reimbursement rates which are central to its revenue strategy. Additionally, the organization benefits from being at the forefront of mental health service delivery innovations, which positions it strategically to adapt and grow in a marketplace that increasingly values integration of mental health into broader healthcare frameworks.